Grantham, Mayo, Van Otterloo & Co (GMO)’s Aptinyx Inc. Common Stock APTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-28,100
Closed -$97K 968
2020
Q4
$97K Buy
+28,100
New +$97.9K ﹤0.01% 791

Other funds holding APTX

Grantham, Mayo, Van Otterloo & Co (GMO)'s APTX Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Aptinyx Inc. Common Stock (APTX) in Q1 2021, closing a stake of 28,100 shares — an estimated $97K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in APTX in Q4 2020 and held it in 1 quarter. The position peaked at $97K in Q4 2020. 70 funds tracked by Wall St. Rank hold APTX as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Aptinyx Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 28,100 Aptinyx Inc. Common Stock shares in Q1 2021, an estimated $97K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Aptinyx Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Aptinyx Inc. Common Stock position peaked at $97K in Q4 2020.
  • 70 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.